Biogen Inc. buy Needham & Company LLC
Start price
30.10.24
/
50%
€166.70
Target price
30.10.25
€248.94
Performance (%)
-22.98%
End price
31.10.25
€128.40
Summary
This prediction ended on 31.10.25 with a price of €128.40. The prediction for Biogen Inc. disappointed with a performance of -22.98%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.438% | -0.438% | 41.855% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $270.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten